Home > Healthcare > Pharmaceuticals > Pharma Exicipients > Pharmaceutical Gelatin Market
Pharmaceutical Gelatin Market size was valued at around USD 1.1 billion in 2022 and is estimated to reach USD 1.9 billion by 2032. Increasing burden of chronic disease is expected to increase the demand for pharmaceutical-grade gelatin.
Also, expanding developments of gelatin nanoparticles in medications and vaccines are driving the market expansion. Growing use of gelatin in cosmetics, intrinsic activities, biomedical applications such as wound treatment & healing, and bone substitutes are observed in several studies with new developments in the market. For instance, according to the National Institute of Health (NIH) study, it was found that bovine hydroxyapatite-gelatin-hydroxypropyl methylcellulose with alendronate was utilized as injectable bone substitute (IBS) for the treatment of bone with osteoporosis in animal model.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Pharmaceutical Gelatin Market Size in 2022: | USD 1.1 billion |
Forecast Period: | 2023 to 2028 |
Forecast Period 2023 to 2028 CAGR: | 5.6% |
2028 Value Projection: | USD 1.9 billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 150 |
Tables, Charts & Figures: | 308 |
Segments covered: | Type, Source, Function, Application and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
Pharmaceutical gelatin is generated from animal skin, white connective tissues, and bones. They comprises high molecular weight, thermo-reversible, biocompatible and are water soluble in nature. It is a common excipient used in the manufacture of hard capsules and soft gels. Furthermore, it is utilized as a binder in tablets, blood plasma substitutes among other applications.